Stay updated on MOCHA Clinical Trial for Child/Adolescent HIV
Sign up to get notified when there's something new on the MOCHA Clinical Trial for Child/Adolescent HIV page.

Latest updates to the MOCHA Clinical Trial for Child/Adolescent HIV page
- Check3 days agoChange DetectedAdded two 2026 Lancet HIV MOCHA publications detailing 48-week results in adolescents; removed outdated 'Online ahead of print' MOCHA citations.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page shows Revision: v3.4.2, replacing the previous v3.4.1. This appears to be a small editorial update and does not affect study content or data.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed.SummaryDifference0.0%

- Check27 days agoChange DetectedMOCHA study page updated to reflect Cohort 2 follow-up extending up to 188 or 192 weeks and revised Step 3–5 dosing for CAB and RPV long-acting injections, including associated pharmacokinetic endpoints.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary display option and a No FEAR Act Data label. The page now shows QC metadata (Last Update Submitted that Met QC Criteria, Last Update Posted) and the revision number (Revision: v3.4.0).SummaryDifference0.2%

- Check35 days agoChange DetectedMOCHA-related publications were added to the Publications section: Lancet HIV 2026 (MOCHA 48-week results) and a companion paper on safety, antiviral activity, and pharmacokinetics. These entries provide the latest study findings.SummaryDifference0.1%

Stay in the know with updates to MOCHA Clinical Trial for Child/Adolescent HIV
Enter your email address, and we'll notify you when there's something new on the MOCHA Clinical Trial for Child/Adolescent HIV page.